FDA chief apologizes: Plasma treatment is not so good
Article continues below
Topics: FDA
Earlier this week, while issuing emergency use authorization or EUA for investigational convalescent plasma to treat coronavirus in hospitalized patients, the FDA had said that the EUA decision was based on scientific data from the preliminary findings of Mayo Clinic observations.
It was also stated that out of 100 people who are sick with coronavirus, 35 would have been saved because of the administration of plasma.
President Donald Trump, in his press briefing to announce the EUA news, on the eve of his Republican National Convention, also called the decision a historic breakthrough.
However, Hahn later tweeted an apology, saying "I have been criticized for remarks I made Sunday night about the benefits of convalescent plasma.
"The criticism is entirely justified.
"What I should have said better is that the data show a relative risk reduction not an absolute risk reduction." ■